Significance of aminopeptidase N/CD13 expression in hepatocellular carcinoma
10.3760/cma.j.issn.1673-4203.2012.06.008
- VernacularTitle:氨肽酶N/CD13在肝癌中的表达及意义
- Author:
Xiewu QIU
;
Conghui YU
;
Jianfei WANG
;
Chao NAI
;
Yuwang TIAN
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
Liver cancer stem cells;
CD13;
Immunohistochemistry
- From:
International Journal of Surgery
2012;39(6):384-387,封3
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study aminopeptidase N/CD13 expression in hepatocellular carcinoma and its relationship with clinical data and proguosis in patients with hepatocellular carcinoma.Methods The immunohistochemical SP method was used to detect the CD13 monoclonal antibody in 40 cases of hepatocellular carcinoma,10 cases of corresponding para-carcinoma and 10 cases of cavernous hemangioma.Results Forty cases ( 100％ ) hepatocellular carcinoma tissues were seen varying degrees of CD13 expression,3 (30％) corresponding para-carcinoma tissues were weakly positive,and 10 cases of cavernous hemangioma with no expression.The expression rate of CD13 was not significantly correlated with the patient gender,age,serum AFP value,HbsAg,differentiation,CHILD grade and TNM stage (P＞0.05).But the expression of CD13 was closely related with the patient serum AFP value,HbsAg,differentiation ( P ＜ 0.05 ).By the survival function graph we could find the expression rate was negativly correlated with survival in patients,but the expression was not significantly correlated with tumor relapse.Conclusion CD13 can be used as the surface marker of liver cancer stem cells,and it is expected to become an effective indicator of prognosis in patients with hepatocellular carcinoma.
